These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 16620274)

  • 1. Diabetes with partial lipodystrophy following sclerodermatous chronic graft vs. host disease.
    Rooney DP; Ryan MF
    Diabet Med; 2006 Apr; 23(4):436-40. PubMed ID: 16620274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of pioglitazone and metformin on intracellular lipid content in liver and skeletal muscle of individuals with type 2 diabetes mellitus.
    Teranishi T; Ohara T; Maeda K; Zenibayashi M; Kouyama K; Hirota Y; Kawamitsu H; Fujii M; Sugimura K; Kasuga M
    Metabolism; 2007 Oct; 56(10):1418-24. PubMed ID: 17884455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term improvement of metabolic control with pioglitazone in a woman with diabetes mellitus related to Dunnigan syndrome: a case report.
    Collet-Gaudillat C; Billon-Bancel A; Beressi JP
    Diabetes Metab; 2009 Apr; 35(2):151-4. PubMed ID: 19249234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of pioglitazone and metformin on plasma adiponectin in newly detected type 2 diabetes mellitus.
    Sharma PK; Bhansali A; Sialy R; Malhotra S; Pandhi P
    Clin Endocrinol (Oxf); 2006 Dec; 65(6):722-8. PubMed ID: 17121522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin and pioglitazone: Effectively treating insulin resistance.
    Staels B
    Curr Med Res Opin; 2006; 22 Suppl 2():S27-37. PubMed ID: 16914073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temporary resolution of insulin requirement in acquired partial lipodystrophy associated with chronic graft-versus-host disease.
    Kimura L; Alvarez G; Li N; Pawlikowska-Haddal A; Moore TB; Casillas J; Lee KW
    Pediatr Blood Cancer; 2017 Jul; 64(7):. PubMed ID: 28371314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glimepiride versus pioglitazone combination therapy in subjects with type 2 diabetes inadequately controlled on metformin monotherapy: results of a randomized clinical trial.
    Umpierrez G; Issa M; Vlajnic A
    Curr Med Res Opin; 2006 Apr; 22(4):751-9. PubMed ID: 16684436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV lipodystrophy and its metabolic consequences: implications for clinical practice.
    Wierzbicki AS; Purdon SD; Hardman TC; Kulasegaram R; Peters BS
    Curr Med Res Opin; 2008 Mar; 24(3):609-24. PubMed ID: 18208641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sclerodermatous chronic graft-versus-host disease--a report of four pediatric cases.
    Tolland JP; Devereux C; Jones FC; Bingham EA
    Pediatr Dermatol; 2008; 25(2):240-4. PubMed ID: 18429789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the effects of pioglitazone and metformin on hepatic and extra-hepatic insulin action in people with type 2 diabetes.
    Basu R; Shah P; Basu A; Norby B; Dicke B; Chandramouli V; Cohen O; Landau BR; Rizza RA
    Diabetes; 2008 Jan; 57(1):24-31. PubMed ID: 17914032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Case Report: Metreleptin and SGLT2 Inhibitor Combination Therapy Is Effective for Acquired Incomplete Lipodystrophy.
    Nagayama A; Ashida K; Watanabe M; Moritaka K; Sonezaki A; Kitajima Y; Takahashi H; Yoshinobu S; Iwata S; Yasuda J; Hasuzawa N; Ozono S; Motomura S; Nomura M
    Front Endocrinol (Lausanne); 2021; 12():690996. PubMed ID: 34135866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct comparison among oral hypoglycemic agents and their association with insulin resistance evaluated by euglycemic hyperinsulinemic clamp: the 60's study.
    Derosa G; Maffioli P; Salvadeo SA; Ferrari I; Gravina A; Mereu R; Palumbo I; D'Angelo A; Cicero AF
    Metabolism; 2009 Aug; 58(8):1059-66. PubMed ID: 19394976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of safety and efficacy of rosiglitazone in the treatment of HIV-associated lipodystrophy syndrome.
    Feldt T; Oette M; Kroidl A; Goebels K; Fritzen R; Kambergs J; Kappert G; Vogt C; Wettstein M; Häussinger D
    Infection; 2006 Apr; 34(2):55-61. PubMed ID: 16703293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and [corrected] hypoadiponectinemia.
    Samaras K; Wand H; Law M; Emery S; Cooper D; Carr A
    Diabetes Care; 2007 Jan; 30(1):113-9. PubMed ID: 17192343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allogeneic stem cell transplantation in first complete remission enhances graft-versus-leukemia effect in adults with acute lymphoblastic leukemia: antileukemic activity of chronic graft-versus-host disease.
    Lee S; Cho BS; Kim SY; Choi SM; Lee DG; Eom KS; Kim YJ; Kim HJ; Min CK; Cho SG; Kim DW; Lee JW; Min WS; Shin WS; Kim CC
    Biol Blood Marrow Transplant; 2007 Sep; 13(9):1083-94. PubMed ID: 17697971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful treatment of refractory joint contractures caused by sclerodermatous graft versus host disease.
    Kim JB; Liakopoulou E; Watson JS
    J Plast Reconstr Aesthet Surg; 2008 Oct; 61(10):1235-8. PubMed ID: 17509955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sclerodermatous graft-versus-host disease: clinical spectrum and therapeutic challenges.
    White JM; Creamer D; du Vivier AW; Pagliuca A; Ho AY; Devereux S; Salisbury JR; Mufti GJ
    Br J Dermatol; 2007 May; 156(5):1032-8. PubMed ID: 17419693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sclerodermatous chronic graft-versus-host disease presenting with dysphagia.
    Tamagawa R; Takenaka H; Katoh N; Shimazaki C; Bamba H; Kishimoto S
    Eur J Dermatol; 2006; 16(1):92-3. PubMed ID: 16436353
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy of pioglitazone in familial partial lipodystrophy of the Dunnigan type: a case report.
    Moreau F; Boullu-Sanchis S; Vigouroux C; Lucescu C; Lascols O; Sapin R; Ruimy D; Guerci B; Pinget M; Jeandidier N
    Diabetes Metab; 2007 Nov; 33(5):385-9. PubMed ID: 17936664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of metformin therapy on plasma adiponectin and leptin levels in obese and insulin resistant postmenopausal females with type 2 diabetes.
    Adamia N; Virsaladze D; Charkviani N; Skhirtladze M; Khutsishvili M
    Georgian Med News; 2007 Apr; (145):52-5. PubMed ID: 17525501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.